Insulin-like growth factor-I produced by seminal vesicles: Relationship to intraepithelial basal cell hyperplasia in the prostate

Clinical Cancer Research

Volumn 13, Issue 11, 2007, Pages 3140-3146

  Garcia, Fernando U ^a   Urbanska, Katarzyna ^b,c   Koltowski, Lauren ^a   Reiss, Krzysztof ^b   Sell, Christian ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P63; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; BASAL CELL; CANCER STEM CELL; CELL HYPERPLASIA; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN PHOSPHORYLATION; SEMEN ANALYSIS; SEMINAL PLASMA; SEMINAL VESICLE;

CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MEMBRANE PROTEINS; PHOSPHORYLATION; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; SEMINAL VESICLES; SIGNAL TRANSDUCTION;

EID: 34250658862     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2607     Document Type: Article

References (28)

1. McNeal JE, Price HM, Redwine EA, Freiha FS, Stamey TA. Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol 1988;139:61-5.
2. Litvinov IV, De Marzo AM, Isaacs JT. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 2003;88:2972-82.
3. Uzgare AR, Xu Y, Isaacs JT. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J Cell Biochem 2004;91:196-205.
4. De Marzo AM, Meeker AK, Epstein JI, Coffey DS. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol 1998;153:911-9.
5. Uzgare AR, Isaacs JT. Prostate cancer: potential targets of anti-proliferative and apoptotic signaling pathways. Int J Biochem Cell Biol 2005;37:707-14.
6. Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992;75:1046-53.
7. Lee KO, Oh Y, Giudice LC, Cohen P, Peehl DM, Rosenfeld RG. Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patients. J Clin Endocrinol Metab 1994;79:1367-72.
8. Rosenfeld RG, Pham H, Oh Y, Lamson G, Giudice LC. Identification of insulin-like growth factor-binding protein-2 (IGF-BP-2) and a low molecular weight IGF-BP in human seminal plasma. J Clin Endocrinol Metab 1990;70:551-3.
9. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-6.
10. Wolk A, Mantzoros CS, Andersson SO, et al. Insulin-like growth factor 1and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 1998;90:911-5.
11. Baffa R, Reiss K, El-Gabry EA, et al. Low serum insulin-like growth factor 1 (IGF-1): a significant association with prostate cancer. Tech Urol 2000;6:236-9.
12. Finne P, Auvinen A, Koistinen H, et al. Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J Clin Endocrinol Metab 2000;85:2744-7.
13. Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 2000;85:4258-65.
14. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
15. Sjogren K, Liu JL, Blad K, et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal sourceof IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 1999;96:7088-92.
16. Chen X, Zhao J, Salim S, Garcia FU. Intraprostatic spermatozoa: zonal distribution and association with atrophy. Hum Pathol 2006;37:345-51.
17. Bright RK, Vocke CD, Emmert-Buck MR, et al. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 1997;57:995-1002.
18. Goodyear SH, Stearns ME. Characterization of adult cancer stem cells isolated from a prostate cancer cell line (IBC-10a) [abstract 318]. Washington (DC): 97th AACR Annual Meeting; 2006.
19. Garcia-Echeverria C, Pearson MA, Marti A, et al. In vivo antitumor activity of NVP-AEW541: a novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 2004;5:231-9.
20. Scotlandi K, Manara MC, Nicoletti G, et al. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. Cancer Res 2005;65:3868-76.
21. Baxter R, Martin J, Handelsman D. Identification of human semen insulin-like growth factor-I/somatomedin-C immunoreactivity and binding protein. Acta Endocrinol 1984;106:420-7.
22. Mullin JM. Epithelial barriers, compartmentation, and cancer. Sci STKE 2004;49:1381-6.
23. Mullin JM, Leatherman JM, Valenzano MC, et al. Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. Mol Biol Cell 2005;16:5538-50.
24. Gorodeski GI, Goldfarb J. Seminal fluid factor increases the resistance of the tight junctional complex of cultured human cervical epithelium CaSki cells. Fertil Steril 1998;69:309-17.
25. Kleine TJ, Gladfelter A, Lewis PN, Lewis SA. Histone-induced damage of a mammalian epithelium: the conductive effect. Am J Physiol 1995;268:C1114-25.
26. Leitzmann MF, Platz EA, Stampfer MJ, Willett WC, Giovannucci E. Ejaculation frequency and subsequent risk of prostate cancer. JAMA 2004;291:1578-86.
27. Giles GG, Severi G, English DR, et al. Sexual factors and prostate cancer. BJU Int 2003;92:211-6.
28. Brody S. Sexual factors and prostate cancer. BJU Int 2004;93:180.